Protein arginine methyltransferases and hepatocellular carcinoma: A review
Hepatocellular carcinoma (HCC) is one of the most frequently diagnosed cancers with a high mortality rate worldwide. The complexity of HCC initiation and progression poses a great challenge to the diagnosis and treatment. An increasing number of studies have focused on the emerging roles of protein...
Main Authors: | Yu Lei, Ping Han, Dean Tian |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-11-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523321001868 |
Similar Items
-
A Pan-Inhibitor for Protein Arginine Methyltransferase Family Enzymes
by: Iredia D. Iyamu, et al.
Published: (2021-06-01) -
Discovery of a potent and dual-selective bisubstrate inhibitor for protein arginine methyltransferase 4/5
by: Ayad A. Al-Hamashi, et al.
Published: (2021-09-01) -
Roles of Protein Arginine Methyltransferases in the Control of Glucose Metabolism
by: Hye-Sook Han, et al.
Published: (2014-12-01) -
Kinetic Mechanism and Inhibitory Study of Protein Arginine Methyltransferase 1
by: Feng, You
Published: (2012) -
Characterization of the Substrate Interactions and Regulation of Protein Arginine Methyltransferase
by: Morales, Yalemi
Published: (2016)